394 related articles for article (PubMed ID: 20871409)
1. Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse.
Gerasimidis K; Nikolaou CK; Edwards CA; McGrogan P
J Clin Gastroenterol; 2011 Mar; 45(3):234-9. PubMed ID: 20871409
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
[TBL] [Abstract][Full Text] [Related]
3. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
Day AS; Whitten KE; Lemberg DA; Clarkson C; Vitug-Sales M; Jackson R; Bohane TD
J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
[TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn disease.
Copova I; Hradsky O; Zarubova K; Gonsorcikova L; Potuznikova K; Lerchova T; Nevoral J; Bronsky J
Eur J Pediatr; 2018 Nov; 177(11):1685-1693. PubMed ID: 30128744
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.
Laharie D; Mesli S; El Hajbi F; Chabrun E; Chanteloup E; Capdepont M; Razaire S; de Lédinghen V; Zerbib F
Aliment Pharmacol Ther; 2011 Aug; 34(4):462-9. PubMed ID: 21671970
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
Jones CMA; Connors J; Dunn KA; Bielawski JP; Comeau AM; Langille MGI; Van Limbergen J
Inflamm Bowel Dis; 2020 Jun; 26(7):1026-1037. PubMed ID: 31961432
[TBL] [Abstract][Full Text] [Related]
7. Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease.
Swaminath A; Feathers A; Ananthakrishnan AN; Falzon L; Li Ferry S
Aliment Pharmacol Ther; 2017 Oct; 46(7):645-656. PubMed ID: 28815649
[TBL] [Abstract][Full Text] [Related]
8. Nutritional therapy for the treatment of pediatric Crohn's disease.
Otley AR; Russell RK; Day AS
Expert Rev Clin Immunol; 2010 Jul; 6(4):667-76. PubMed ID: 20594139
[TBL] [Abstract][Full Text] [Related]
9. Exclusive enteral nutrition in the treatment of children with Crohn's disease in Sweden: a questionnaire survey.
Gråfors JM; Casswall TH
Acta Paediatr; 2011 Jul; 100(7):1018-22. PubMed ID: 21272070
[TBL] [Abstract][Full Text] [Related]
10. The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission.
Buchanan E; Gaunt WW; Cardigan T; Garrick V; McGrogan P; Russell RK
Aliment Pharmacol Ther; 2009 Sep; 30(5):501-7. PubMed ID: 19549288
[TBL] [Abstract][Full Text] [Related]
11. The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction.
Logan M; Clark CM; Ijaz UZ; Gervais L; Duncan H; Garrick V; Curtis L; Buchanan E; Cardigan T; Armstrong L; Delahunty C; Flynn DM; Barclay AR; Tayler R; McDonald E; Milling S; Hansen RK; Gerasimidis K; Russell RK
Aliment Pharmacol Ther; 2019 Sep; 50(6):664-674. PubMed ID: 31342536
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of nutritional therapy in paediatric Crohn's disease.
Knight C; El-Matary W; Spray C; Sandhu BK
Clin Nutr; 2005 Oct; 24(5):775-9. PubMed ID: 15904998
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
Zhou S; Huang Z; Hou W; Lin Y; Yu J
Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
[TBL] [Abstract][Full Text] [Related]
14. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition.
Afzal NA; Van Der Zaag-Loonen HJ; Arnaud-Battandier F; Davies S; Murch S; Derkx B; Heuschkel R; Fell JM
Aliment Pharmacol Ther; 2004 Jul; 20(2):167-72. PubMed ID: 15233696
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding.
Rubio A; Pigneur B; Garnier-Lengliné H; Talbotec C; Schmitz J; Canioni D; Goulet O; Ruemmele FM
Aliment Pharmacol Ther; 2011 Jun; 33(12):1332-9. PubMed ID: 21507029
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
17. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
[TBL] [Abstract][Full Text] [Related]
18. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
Zubin G; Peter L
Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
[TBL] [Abstract][Full Text] [Related]
19. Reverse-engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial.
Lee D; Braly K; Nuding M; Braly I; Hopp C; Twible H; Pope C; Hayden HS; Hoffman L; Zheng H; Wahbeh G; Suskind DL
J Pediatr Gastroenterol Nutr; 2024 May; 78(5):1135-1142. PubMed ID: 38558411
[TBL] [Abstract][Full Text] [Related]
20. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
